00:12 24-09-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
18:43 Sponsorship fees collected from parents forcibly at Kyrgyz schools reach $45 million annually – research18:33 Maksim Bakiyev's extradition to be discussed during visit of British Minister of Justice to Bishkek – British MPs18:22 British MPs invite Speaker Jeenbekov to visit London18:14 Kyrgyz government warns about critical situation with water accumulation in Toktogul dam18:10 Overall budget of current road construction projects reaches $550 million – Transport Ministry18:03 Saudi Arabia asks 4 ha of land in Bishkek for construction of Islamic Cultural Center17:59 Kyrgyzstanis win silver medals at youth tennis tournament in Kazakhstan17:53 Central Election Commission, British MPs discuss Kyrgyzstan's electoral system17:47 9.6 billion kWh of electricity produced in Kyrgyzstan for 8 months of 201417:44 MP Isakov: Interior Ministry violates rights of citizens to hold peaceful rallies17:38 French tourist abducted by Algeria militants - FM17:33 Around 62% of Kyrgyzstan population support country's Customs Union accession – Economy Minister17:30 Kyrgyzstan's Izat Artykov takes 5th place in weightlifting competition of XVII Asiad17:28 Egyptian security services detain four Tajik citizens in Cairo suburb17:27 Kazakhstani swimmer wins fourth gold in 2014 Asian Games in Incheon17:22 Adoption of law on state language has become significant step in building independent state, President Atambayev says17:20 Delegation of Kyrgyzstan to attend 69th session of UN General Assembly17:09 Social Development Ministry's budget for 2015 reduced by 10 mln som17:01 Israel downs Syrian warplane it says violated its Golan airspace17:01 Uz-Daewoo to launch production of crossover, minivan in Uzbekistan
Astana
+17° C
Ashgabat
+30° C
Bishkek
+25° C
Dushanbe
+24° C
Tashkent
+27° C
exchange rates
 
69.62
54.20
8.82
1.40
233.75
181.95
29.63
4.71
6.42
4.99
0.81
0.13
3122.57
2363.47
385.06
61.53
3.66
2.85
0.46
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75